A randomised study of 10 μg/kg/day (single dose) vs 2 × 5 μg/kg/day (split dose) G-CSF as stem cell mobilisation regimen in high-risk breast cancer patients

Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor

Jean-Pierre Lévesque, Yasushi Takamatsu, Susan K. Nilsson et al. · Blood · 2001 · 481 citations · Full text

Life Sciences, Hematology, Immunology +17

Current trends in hematopoietic stem cell transplantation in Europe

Aloïs Gratwohl, Helen Baldomero, Bruno Horisberger et al. · Blood · 2002 · 212 citations

Medicine, Hematology, Surgery +14

A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation

Nicolaus Kröger, Helmut Renges, William Krüger et al. · British Journal of Haematology · 2000 · 96 citations

Medicine, Hematology, Immunology +16

Randomized Cross-Over Trial of Progenitor-Cell Mobilization: High-Dose Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor (G-CSF) Versus Granulocyte-Macrophage Colony-Stimulating Factor Plus G-CSF

Omer N. Koç, Stanton L. Gerson, Brenda Cooper et al. · Journal of Clinical Oncology · 2000 · 94 citations

Medicine, Hematology, Pharmacology +17

Crossover study of the haematological effects and pharmacokinetics of glycosylated and non‐glycosylated G‐CSF in healthy volunteers

Michael Watts, Ian E. Addison, S. G. Long et al. · British Journal of Haematology · 1997 · 68 citations · Full text

Pharmacy, Hematology, Pharmacokinetics +12